-0.06 | -0.23%
| Price and Volume | |
|---|---|
| Recent Price | 26.01 |
| 52 Week High | 26.62 |
| 52 Week Low | 18.83 |
| Avg. Daily Vol. (Mil) | 15.37 |
| Beta (3 year) | 0.68 |
| Share Related Items | |
| Mkt Cap (Mil) | 44,584.80 |
| Shares Out (Mil) | 1,714.14 |
| Float (Mil) | 1,979.83 |
| Dividend Information | |
| Yield % | 4.90 |
| Annual Dividend | 1.28 |
| Payout Ratio | 77.00 |
| Financial Strength | |
| Quick Ratio | 1.80 |
| Current Ratio | 2.20 |
| LT Debt/ Equity | 0.41 |
| Total Debt / Equity | 0.43 |
| Valuation Ratios | |
| Price Earnings | 16.00 |
| Price/Sales | 2.37 |
| Price/Book | 3.00 |
| Price/Cash Flow | 3.90 |
| Per Share Data | |
| Earnings | 1.63 |
| Sales | 10.97 |
| Book Value | 8.66 |
| Cash Flow | 6.64 |
| Business Summary | |
|---|---|
| A global biopharmaceutical company, which is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis. | |
| General Information | |
| 345 Park Avenue
New York, NY 10154 |
|
| www.bms.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 28000 | |
| CEO: James M. Cornelius | |
| Short Interest | |
| Current Month (Mil) | 38.89 |
| Previous Month (Mil) | 42.11 |
| Short Interest Ratio (Days) | 3.40 |
| Management Effectiveness | |
| Return on Equity | 72.00 |
| Return on Assets | 34.40 |
| Return on Investments | 50.90 |
| Profitability | |
| Gross Margin | 76.40 |
| EBIT Margin | 31.10 |
| Profit Margin | 56.80 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,741.98 | 1,159.90 | 2,374.41 | 36.87 |
Oil *
79.80
|
|
DOWN
37.19
|
DOWN
5.92
|
DOWN
16.87
|
UP
0.15
|
10 Yr
3.69%
SPDR Gold
108.28
|
|
-0.34%
|
-0.51%
|
-0.71%
|
+0.41%
|
Data delayed 20 minutes |
Connect with TheStreet